Penn Medicine's 2020 Updates in Care of the Hematologic Malignancies Patient
ASH 2019 Updates on MDS Treatment: Luspatercept Reduces Anemia, Lenalidomide and Epoetin Alfa Leads to Durable Responses, Experience with HMAs, ASTX727 as Alternative to IV Decitabine
Comments 0
Login to view comments.
Click here to Login
